GDF15 and malignant colon neoplasm: Intraperitoneal perfusion therapy targeting the GDF15-POSTN axis may reduce intraperitoneal metastasis and the formation of ascites in patients with colon cancer, but this approach needs to be further validated in vivo and in clinical trials.